EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa

Q C Truong-Bolduc iD, Y Wang, B G Lawton, J J Zweifach, G M McDevitt, Y El Abdellaoui, H Brown Harding, L M Yonker iD, L G Rahme, J M Vyas, D C Hooper iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00460-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Q C Truong-Bolduc und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Division and Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Cystic Fibrosis, Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efflux pumps play multiple roles in bacterial physiology, environmental adaptation, and antibiotic resistance. Early cystic fibrosis (CF) airway infections start with Staphylococcus aureus ( SA ), often later followed by Pseudomonas aeruginosa ( PA ) infections. In this study, we have evaluated the role of SA pumps NorA and Tet38 in survival and interaction with PA in CF patients. Data showed a ≥4-log 10 CFU/mL growth deficit of SA mutants ΔnorA and Δtet38 in an artificial sputum medium (ASM), suggesting NorA and Tet38 contributed to SA growth in CF sputum. In ASM, mucin activated norA but inhibited tet38, while extracellular DNA activated tet38 but inhibited norA , demonstrating complementary roles of mucin and DNA in affecting NorA and Tet38 expression. Furthermore, exposure of SA wild type to PA -excreted molecules affected pump expression; 3,4-dihydroxy-2-heptylquinoline PQS caused an increase in tet38 but a decrease in norA , 4-hydroxy-2-heptylquinoline HHQ caused a decrease in norA and tet38 , and pyocyanin PYO caused a modest increase in norA , demonstrating differing additional roles of PA -secreted molecules influencing NorA and Tet38 expression. Evaluation of 48 randomly selected unique CF-associated SA showed that 18.8% were NorA-overexpressors and 10.4% were Tet38-overexpressors. NorA-overexpressors showed a fourfold increase in pyocyanin MIC and ≥16-fold in ciprofloxacin MIC. Furthermore, 89% of NorA-overexpressors carried an insertion of CAAT/ACAA/CTAT at the (−10) motif of the norA promoter, and 62.5% of these were co-isolated with PA . These data showed that SA survives PA killing in CF sputum conditions using sputum key components and PA -specific signal molecules to regulate NorA and Tet38 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaCystic FibrosisStaphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsPseudomonas InfectionsATP-Binding Cassette, Sub-Family C ProteinsHumansCoinfectionMicrobial Sensitivity TestsStaphylococcal InfectionsSputum

Stichwörter der Autor:innen

NorAP. aeruginosaS. aureusTet38cystic fibrosisefflux pump

Substanzen

Anti-Bacterial AgentsBacterial ProteinsATP-Binding Cassette, Sub-Family C ProteinsNorA protein, Staphylococcus

Autor:innen und Institutionen

  • Infectious Diseases Division and Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Q C Truong-Bolduc, L M Yonker, D C Hooper

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Truong-Bolduc, Q. C., Wang, Y., Lawton, B. G., Zweifach, J. J., McDevitt, G. M., El Abdellaoui, Y., Brown Harding, H., Yonker, L. M., Rahme, L. G., Vyas, J. M., & Hooper, D. C. (2025). NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00460-25

Vancouver

Truong-Bolduc QC, Wang Y, Lawton BG, Zweifach JJ, McDevitt GM, El Abdellaoui Y, et al. NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00460-25

BibTeX
@article{TruongBolduc2025,
  author = {Truong-Bolduc, Q C and Wang, Y and Lawton, B G and Zweifach, J J and McDevitt, G M and El Abdellaoui, Y and Brown Harding, H and Yonker, L M and Rahme, L G and Vyas, J M and Hooper, D C},
  title = {NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00460-25}
}
Kostenlos starten →